Salarius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor.
CEOMark J. Rosenblum
CEOMark J. Rosenblum
Employees2
Employees2
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2014
Founded2014
Employees2
Employees2
SLRX Key Statistics
Market cap3.46M
Market cap3.46M
Price-Earnings ratio-0.08
Price-Earnings ratio-0.08
Dividend yield—
Dividend yield—
Average volume249.01K
Average volume249.01K
High today$3.90
High today$3.90
Low today$3.16
Low today$3.16
Open price$3.75
Open price$3.75
Volume182.54K
Volume182.54K
52 Week high$108.00
52 Week high$108.00
52 Week low$3.16
52 Week low$3.16
SLRX News
TipRanks 2d
Salarius Pharmaceuticals Approves CEO Bonus for MergerElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own SLRX. This list is generated using Robinhood data, and it’s not a recommendation.